| 12391933 |
Targeted gene insertion for improved immune cells therapy |
Brian BUSSER, Philippe Duchateau, Alexandre Juillerat, Laurent POIROT |
2025-08-19 |
| 12221478 |
Targeted gene integration of CRS inhibitor genes for improved immune cells therapy |
Brian BUSSER, Philippe Duchateau, Alexandre Juillerat, Laurent POIROT, Mohit Sachdeva |
2025-02-11 |
| 12209125 |
Targeted gene integration of NK inhibitors genes for improved immune cells therapy |
Brian BUSSER, Philippe Duchateau, Alexandre Juillerat, Laurent POIROT |
2025-01-28 |
| 11912776 |
Chimeric antigen receptors targeting B-cell maturation antigen |
Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Philippe Duchateau, Roman Galetto +6 more |
2024-02-27 |
| 11903968 |
Engineered immune cells resistant to tumor microenvironment |
Philippe Duchateau, Anne-Sophie GAUTRON, Laurent POIROT |
2024-02-20 |
| 11873511 |
Targeted gene insertion for improved immune cells therapy |
Brian BUSSER, Philippe Duchateau, Alexandre Juillerat, Laurent POIROT |
2024-01-16 |
| 11312782 |
Chimeric antigen receptors targeting B-cell maturation antigen |
Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Philippe Duchateau, Roman Galetto +6 more |
2022-04-26 |
| 11220683 |
Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains |
Philippe Duchateau |
2022-01-11 |
| 11198856 |
Method for the generation of compact tale-nucleases and uses thereof |
Philippe Duchateau, Claudia Bertonati, Jean-Charles Epinat, George H. Silva, Alexandre Juillerat +1 more |
2021-12-14 |
| 11186824 |
Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients |
Philippe Duchateau, Jean-Pierre Cabaniols, Laurent POIROT |
2021-11-30 |
| 11136566 |
Tale-protein scaffolds and uses thereof |
Philippe Duchateau, Alexandre Juillerat, Claudia Bertonati, Jean-Charles Epinat, George H. Silva |
2021-10-05 |
| 11014989 |
Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy |
Julianne Smith, Alexandre Juillerat, Philippe Duchateau, Barbra Johnson SASU, Arvind Rajpal |
2021-05-25 |
| 10894093 |
Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation |
Veronique Zennou, Philippe Duchateau, Laurent POIROT |
2021-01-19 |
| 10813951 |
Method of engineering chemotherapy drug resistant T-cells for immunotherapy |
Philippe Duchateau, David Sourdive |
2020-10-27 |
| 10526406 |
Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish |
Philippe Duchateau |
2020-01-07 |
| 10472396 |
Modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins |
Claudia Bertonati, Philippe Duchateau, Alexandre Juillerat, George H. Silva |
2019-11-12 |
| 10301614 |
Method to overcome DNA chemical modifications sensitivity of engineered tale DNA binding domains |
Philippe Duchateau |
2019-05-28 |
| 10294304 |
Chimeric antigen receptors targeting B-cell maturation antigen |
Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Philippe Duchateau, Roman Galetto +6 more |
2019-05-21 |
| 10239948 |
Method of engineering multi-input signal sensitive T cell for immunotherapy |
Alexandre Juillerat, Claudia Bertonati, Philippe Duchateau, Laurent POIROT |
2019-03-26 |
| 9315788 |
Method for the generation of compact TALE-nucleases and uses thereof |
Philippe Duchateau, Claudia Bertonati, Jean-Charles Epinat, George H. Silva, Alexandre Juillerat +1 more |
2016-04-19 |
